2012 Lung Cancer Research Foundation Annual Grant Program
Jay Tichelaar, PhD
Medical College of Wisconsin
Research Project:
AP-1 as a therapeutic target in TKI resistant lung cancer
Summary:
The study evaluates the impact of blocking a specific genetic transcription factor in lung cancer cells. The association of specific mutations in these cells and outcome of this blockage could lead to useful clinical prognostic information.